⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ruxolitinib phosphate

Every month we try and update this database with for ruxolitinib phosphate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisNCT02528877
Acute Myeloid L...
Primary Myelofi...
Primary Myelofi...
Secondary Acute...
Secondary Myelo...
Allogeneic Bone...
Allogeneic Hema...
Fludarabine Pho...
Laboratory Biom...
Melphalan
Peripheral Bloo...
Pharmacological...
Ruxolitinib Pho...
Sirolimus
Tacrolimus
18 Years - 75 YearsCity of Hope Medical Center
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaNCT02779283
Acute Lymphobla...
Acute Myeloid L...
Cyclophosphamid...
Cytarabine
Dasatinib
Dexamethasone
Doxorubicin Hyd...
Idarubicin
Idelalisib
In Vitro Kinase...
Leucovorin Calc...
Methotrexate
Methylprednisol...
Ponatinib Hydro...
Rituximab
Ruxolitinib Pho...
Sorafenib Tosyl...
Sunitinib Malat...
Vincristine Sul...
18 Years - 64 YearsOHSU Knight Cancer Institute
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeNCT06128070
Acute Lymphobla...
Acute Myeloid L...
Myelodysplastic...
Biospecimen Col...
Chest Computed ...
Echocardiograph...
Hematopoietic C...
Methotrexate
Multigated Acqu...
Ruxolitinib Pho...
Tacrolimus
2 Years - 22 YearsCity of Hope Medical Center
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic LeukemiaNCT02420717
Recurrent B Acu...
Recurrent Ph-Li...
Refractory B Ac...
Refractory Ph-L...
Cyclophosphamid...
Cytarabine
Dasatinib
Dexamethasone
Doxorubicin
Laboratory Biom...
Leucovorin
Mercaptopurine
Methotrexate
Prednisone
Rituximab
Ruxolitinib Pho...
Vincristine
10 Years - M.D. Anderson Cancer Center
Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic LeukemiaNCT02131584
Chronic Lymphoc...
Questionnaire A...
Ruxolitinib Pho...
18 Years - M.D. Anderson Cancer Center
Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast CancerNCT03012230
Metastatic Mali...
Stage IV Breast...
Triple-Negative...
Laboratory Biom...
Pembrolizumab
Ruxolitinib Pho...
18 Years - Mayo Clinic
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell TransplantNCT01431209
Recurrent Diffu...
Recurrent Matur...
Refractory Diff...
Refractory Matu...
Laboratory Biom...
Ruxolitinib Pho...
18 Years - University of Nebraska
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeNCT06128070
Acute Lymphobla...
Acute Myeloid L...
Myelodysplastic...
Biospecimen Col...
Chest Computed ...
Echocardiograph...
Hematopoietic C...
Methotrexate
Multigated Acqu...
Ruxolitinib Pho...
Tacrolimus
2 Years - 22 YearsCity of Hope Medical Center
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid LeukemiaNCT02092324
Atypical Chroni...
Chronic Neutrop...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
Ruxolitinib Pho...
18 Years - OHSU Knight Cancer Institute
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: